Several independent clinical studies (14–16, 18–21) and meta-analysis (17) confirmed that insulin use increased the risks of DME in patients with type 2 diabetes mellitus (T2DM) compared with oral hypoglycemic agents. Here, INS is linked to diabetes mellitus.